Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
about
Protein kinase C signaling and cell cycle regulationOverexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesisProtein kinase C iota: human oncogene, prognostic marker and therapeutic targetEmerging role of cell polarity proteins in breast cancer progression and metastasisAtypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymesComprehensive molecular characterization of clear cell renal cell carcinoma.Asymmetric cell division of stem and progenitor cells during homeostasis and cancerThe landscape of somatic copy-number alteration across human cancers.Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion.Coordination of glioblastoma cell motility by PKCιScribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs.Scribble at the crossroads.The biology of ovarian cancer: new opportunities for translationOvarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer.Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasisAbortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells.The F-box protein Slmb restricts the activity of aPKC to polarize epithelial cellsCopy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.Regulation of glioblastoma cell invasion by PKC iota and RhoB.Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iotaA novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression.Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanismExpression of polarity genes in human cancer.Atypical protein kinase C zeta: potential player in cell survival and cell migration of ovarian cancer.EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancerPartitioning-defective protein 6 (Par-6) activates atypical protein kinase C (aPKC) by pseudosubstrate displacement.Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin ReceptorExpression of Par3 polarity protein correlates with poor prognosis in ovarian cancerPKCζ Promotes Breast Cancer Invasion by Regulating Expression of E-cadherin and Zonula Occludens-1 (ZO-1) via NFκB-p65.The Par complex and integrins direct asymmetric cell division in adult intestinal stem cells.PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways.Protein kinase Calpha and epsilon small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery?Instructive role of aPKCzeta subcellular localization in the assembly of adherens junctions in neural progenitors.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
P2860
Q21131217-40C594F5-2E77-4DDF-B698-AB1BB0D65B9DQ24317766-61D2490C-2A7B-435C-9C85-C66395B43A64Q24652905-8F2A355A-6722-43A3-BF3E-4554480F8CF2Q26851833-1F78BA03-7DF0-4575-A40B-0D286206762CQ27305890-55C8AF1F-2CB9-4CA2-B0A0-3EE444BD0764Q27684030-F80EDBBB-30F5-47B4-9452-5FB7408F6C29Q27852374-DB4A5227-82AF-44F9-9C59-84E1DBBC0B1DQ28292920-8C5E2762-14C6-4B43-8DD6-0BCAA391B6EDQ29547648-888388A9-1C78-4F40-8C1D-253B586F09F2Q30370835-BCC754AF-66EC-42E5-A27C-EB3EEDBAD31BQ30496644-251D1C50-3ACD-4D01-B5D6-1EFE9486D9A5Q33506529-E84627B7-91C8-4D69-8055-C5EA043C14DBQ33522325-56D40224-5757-49D8-A878-A0DD7082917DQ33622369-E2EB317C-1ECD-40D3-969F-6824AC5894B7Q33748323-94A233BE-9C2D-457B-A99A-6412756C0AB9Q33827549-1E6600FB-9586-442E-AFCD-E50B2612089BQ33836807-F1A4EE7D-5D12-44A3-9277-A1D0CB166EA7Q34038395-41D1FFCF-136F-4508-B0BE-8750386CE68EQ34321373-6EB23B0F-9B98-4A6C-88E2-3CECDEEF3685Q34341659-26CF8038-C6B4-45FF-9492-EC22B1B6DA75Q34664892-A1A33DE7-DF0B-42F2-BCB9-D050643DF490Q34739540-14DDCD84-164B-44E8-80CD-91BAC361301FQ34787801-3FDA8C16-AEF1-4B93-B541-803586463FA4Q34828123-BC756629-6134-4437-832E-2EAC9D10F7DFQ34956519-4838DEC9-9E20-44BE-B53F-79530F9E3738Q34981351-6E5FDC5F-56E2-4F39-AA1F-5A5FA4636C70Q35323930-645036A6-2FDA-42B2-B7FC-A20BFB009E1FQ35416040-87D1951C-7DA1-4AA6-8163-E0F2BC9F3AE9Q35904233-470072A6-B06F-4E58-B1A5-FD56C58F6227Q35992948-DCAF66A0-88A3-4A7A-B8FB-E9E35985C81FQ36033174-370178D1-932C-430E-9755-30A83A3EE8F1Q36082365-ED31BB9B-E3B8-4CFE-ACFE-DE35E280D4C4Q36106815-8A22D0DD-F842-4287-9316-2EE8B13C2144Q36195495-9D1CF68C-21BE-4F53-A56E-3497B4D8F31AQ36288745-B8B538DD-A5F9-4EC5-A2E5-542D94B24BC5Q36301305-19CA4873-2FFD-4458-ABCF-E89BFF22E2E6Q36328818-0235428A-1D6B-41B3-8B70-AD3A63004A7BQ36381266-4B43C7D6-E0BC-4E5C-9BC2-EB036CEE30D2Q36423540-6FF63F71-0B4F-4E26-864C-85A2D2AF55BEQ36510237-44345591-6721-47F1-8873-CA9F9ECA231D
P2860
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Atypical PKCiota contributes t ...... rexpression in ovarian cancer.
@ast
Atypical PKCiota contributes t ...... rexpression in ovarian cancer.
@en
type
label
Atypical PKCiota contributes t ...... rexpression in ovarian cancer.
@ast
Atypical PKCiota contributes t ...... rexpression in ovarian cancer.
@en
prefLabel
Atypical PKCiota contributes t ...... rexpression in ovarian cancer.
@ast
Atypical PKCiota contributes t ...... rexpression in ovarian cancer.
@en
P2093
P2860
P356
P1476
Atypical PKCiota contributes t ...... erexpression in ovarian cancer
@en
P2093
Astrid M Eder
Carla L Warneke
Daniel G Rosen
Edward N Atkinson
Gordon B Mills
Isabelle Bedrosian
Jerry C P Yin
Jinsong Liu
Joe W Gray
John P Lahad
P2860
P304
12519-12524
P356
10.1073/PNAS.0505641102
P407
P577
2005-08-22T00:00:00Z